CXCL8 and cancer: Interestingly, tumor-derived CXCL8 and phosphatase and tensin homolog (PTEN)-deficient cancer cells increase their sensitivity and reactivity to stromal chemokines by upregulating the expression of receptors in cancer cells and inducing stromal chemokine synthesis (Maxwell, Neisen, Messenger, & Waugh, 2014).